Changes in T helper cell-related factors in patients with type 2 diabetes mellitus after empagliflozin therapy
Shiva Borzouei, Hamid Moghimi, Alireza Zamani, Mahdi Behzad
Topics & Concepts
EmpagliflozinMedicineFOXP3Type 2 diabetesMetforminInternal medicineEndocrinologyDiabetes mellitusImmunologyImmune systemDiabetes and associated disordersDiabetes Treatment and ManagementImmunodeficiency and Autoimmune Disorders